Satellos Bioscience Inc. (MSCL.TO)
CAD 0.89
(-4.3%)
CAD 0.89
(-4.3%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.18 CAD | 43.75% |
| 2022 | -0.32 CAD | 50.0% |
| 2021 | -0.64 CAD | -1233.33% |
| 2020 | -0.05 CAD | 73.33% |
| 2019 | -0.18 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.06 CAD | -5.87% |
| 2024 Q2 | -0.05 CAD | 12.72% |
| 2023 Q3 | -0.03 CAD | 39.73% |
| 2023 FY | - CAD | 43.75% |
| 2023 Q2 | -0.05 CAD | -32.16% |
| 2023 Q1 | -0.04 CAD | 66.83% |
| 2023 Q4 | -0.06 CAD | -82.65% |
| 2022 Q4 | -0.12 CAD | -120.59% |
| 2022 FY | - CAD | 50.0% |
| 2022 Q3 | -0.05 CAD | 0.0% |
| 2021 FY | - CAD | -1233.33% |
| 2020 FY | - CAD | 73.33% |
| 2019 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Appili Therapeutics Inc. | -0.03 CAD | -476.923% |
| Eupraxia Pharmaceuticals Inc. | -1.58 CAD | 88.608% |
| Helix BioPharma Corp. | -0.21 CAD | 14.286% |
| Microbix Biosystems Inc. | -0.00 CAD | -59900.0% |
| Medicenna Therapeutics Corp. | -0.37 CAD | 51.351% |
| Oncolytics Biotech Inc. | -0.41 CAD | 56.098% |
| Sernova Corp. | -0.13 CAD | -38.462% |